The life sciences industry in Asia Pacific has been growing at breakneck speed. The law and regulations surrounding the industry, as well as industry codes of practice, have been increasing exponentially. Certainty and consistency in the application of these new laws, regulation and codes, so important to efficient business practices,has been uneven. These developments challenge companies to adapt, change and evolve faster to be able to respond with new internal processes and behaviors.
Hogan Lovells is pleased to be working with Asia Pacific Healthcare Industry Compliance Team, a voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel, in the Second Asia Pacific Pharmaceutical Compliance Congress and Best Practices Forum on 11 - 13 September 2012.
The Congress will focus on the regulatory and compliance concerns for pharmaceutical companies doing business in China, and brings together an international panel of expert speakers, including Eugene Chen, partner at Hogan Lovells' Shanghai office, who will be joining discussions on anti-corruption and government investigations. Jun Wei, managing partner at Hogan Lovells' Beijing office, is a member of Asia Pacific Pharma Congress Planning Committee.
We are able to offer you a special discount on registration fees. If you are interested in attending the Congress, please contact us before registering online .
We look forward to seeing you at the conference in Shanghai.
For further information, please see www.AsianPharmaCongress.com